Target intelligence / Profile preview

Epithelial sodium channel subunit beta (SCNN1B)

Target
SCNN1B
Molecular classification
Ion channel
01

Overview

Epithelial sodium channel subunit beta (SCNN1B), also known as amiloride-sensitive sodium channel subunit beta, is a key component of the heterotrimeric epithelial sodium channel (ENaC). ENaC is a non-voltage-gated, amiloride-sensitive channel primarily expressed in the apical membrane of tight epithelia, including the distal nephron of the kidney, respiratory airways, colon, and sweat glands. It plays a critical role in regulating body fluid volume, sodium balance, and systemic blood pressure by mediating the electrogenic reabsorption of sodium ions, with water following osmotically.

Mutations in the SCNN1B gene are associated with severe human disorders. Gain-of-function mutations that disrupt the channel's degradation pathway lead to Liddle syndrome, an autosomal dominant form of severe, early-onset hypertension characterized by hypokalemia and suppressed renin and aldosterone levels. Conversely, loss-of-function mutations cause autosomal recessive pseudohypoaldosteronism type 1 (PHA1B), a life-threatening salt-wasting syndrome characterized by severe hyponatremia, hyperkalemia, and dehydration. SCNN1B is a well-established therapeutic target; classic potassium-sparing diuretics such as amiloride and triamterene act as direct blockers of the ENaC pore, thereby promoting natriuresis while conserving potassium. Additionally, novel therapeutic strategies, such as SCNN1B-targeting siRNAs, are being explored for respiratory conditions like cystic fibrosis and chronic obstructive pulmonary disease to restore airway surface liquid hydration.

Other names
Amiloride-sensitive sodium channel subunit betaBeta-ENaCENaC subunit betaENaCBEpithelial Na(+) channel subunit betaBeta-NaCHNonvoltage-gated sodium channel 1 subunit betaSCNEBBESC1LIDLS1PHA1B2
02

Mechanism of action

Epithelial sodium channel blocker, gene silencing

03

Biological functions

Other
04

Disease associations

Cardiovascular diseaseOther
05

Safety considerations

HyperkalemiaHyponatremiaDehydrationHypotensionMetabolic acidosis
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

Serum potassium levelsSerum sodium levelsPlasma renin activityAldosterone levelsBlood pressureSCNN1B gene mutations

Beyond the preview

Go deeper on Epithelial sodium channel subunit beta (SCNN1B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epithelial sodium channel subunit beta (SCNN1B).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call